Author:
Kim Sung-Jo,Hwang Eunmi,Yi Sun Shin,Song Ki Duk,Lee Hak-Kyo,Heo Tae-Hwe,Park Sang-Kyu,Jung Yun Joo,Jun Hyun Sik
Funder
Rural Development Administration
Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,General Medicine,Bioengineering,Biotechnology
Reference47 articles.
1. Kuijlen, J. M., Bremer, E., Mooij, J. J., den Dunnen, W. F., & Helfrich, W. (2010). Review: on TRAIL for malignant glioma therapy? Neuropathology and Applied Neurobiology, 36, 168–182.
2. Karpel-Massler, G., Schmidt, U., Unterberg, A., & Halatsch, M. E. (2009). Therapeutic inhibition of the epidermal growth factor receptor in high-grade gliomas: where do we stand? Molecular cancer research: MCR, 7, 1000–1012.
3. Narayana, A., Kelly, P., Golfinos, J., Parker, E., Johnson, G., Knopp, E., et al. (2009). Antiangiogenic therapy using bevacizumab in recurrent high-grade glioma: impact on local control and patient survival. Journal of Neurosurgery, 110, 173–180.
4. Iacob, G., & Dinca, E. B. (2009). Current data and strategy in glioblastoma multiforme. Journal of Medicine and Life, 2, 386–393.
5. Kamata, H., & Hirata, H. (1999). Redox regulation of cellular signalling. Cellular Signalling, 11, 1–14.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献